Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Disposable Duodenoscope Elevator Caps Appear Effective in Preventing Infections, Study Finds Standard duodenoscopes were three times as likely to have persistent microbial contamination when compared to duodenoscopes with disposable elevator caps January 25, 2023 Irvin Jackson Add Your Comments Following a number of deadly hospital infection outbreaks in recent years, where “superbug” infections were spread among patients undergoing procedures involving the same duodenoscope devices, the finding of a new study suggests that a switch to using endoscopes with disposable elevator caps has greatly reduced the risks. Duodenoscopes are a type of endoscope used during endoscopic retrograde cholangiopancreatography (ERCP) procedures. However, difficulties cleaning device manufactured by several different companies have resulted in a number of problems in recent years, typically involving aggressive infections that are resistant to available antibiotics, and often result in life-threatening injuries. Concerns about the risk of duodenoscope infections emerged about seven years ago, following infection outbreaks at a number of different hospitals. Investigations by health officials identified problems with the cleaning procedures provided by Olympus and other manufacturers, which may allow the devices to transfer tissue or bacteria between patients. In response to a continuing risk of problems, the FDA issued a safety communication in April 2022, urging hospitals nationwide to change over to using disposable duodenoscopes and disposable duodenoscope parts. In a study published this month in the medical journal JAMA Internal Medicine, Canadian researchers indicate that the use of duodenoscopes with disposable elevator caps results in a two-thirds reduction in detectable microbial contamination. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Researchers conducted a randomized clinical trial that involved 518 patients undergoing ERCP between December 2019 and February 2022. Half underwent the procedure with traditional duodenoscopes, while duodenoscopes using disposable elevator caps were used on the other half of the patients. According to the findings, persistent microbial contamination was detected in 11.2% of the standard duodenoscopes, but that contamination was only found on 3.8% of duodenoscopes with disposable elevator caps. Contamination appeared to be reduced by two-thirds when duodeonscopes with disposable elevator caps were used, the researchers determined. “In this randomized clinical trial, disposable elevator cap duodenoscopes exhibited lower rates of persistent microbial contamination after high-level disinfection compared with standard duodenoscopes while maintaining noninferior rates of technical performance for ERCP,” the researchers concluded. “There were no differences between study groups for adverse events, ease of duodenoscope use, or patient tolerability. These results were consistent across all clinically relevant subgroups.” FDA Promotes Use of Disposable Endoscope Components Due to Infection Risks Questions about the safety of the devices first emerged after a duodenoscope infection outbreak at UCLA’s Ronald Reagan Medical Center in February 2015, involving carbapenem-resistant enterobacteriaceae (CRE) infections, which resulted in at least seven infections and two deaths. At least 200 other patients had to undergo testing after being placed at risk by duodenoscopes manufactured by Olympus Corp. The infections were linked to problems with the “reprocessing” instructions provided by the manufacturer, which are used to clean the devices for use by another patient. FDA reviewers determined at that time that the instructions sent out at the time were inadequate, and that even if the recommended steps were followed to clean ERCP endoscopes, flaws in the design may allow them to become easily contaminated. In response to the problem, the FDA approved the first design with a disposable elevator tip, the most problematic and hard to clean part of the duodenoscope, in November 2019. Now, the agency says there are enough various disposable parts and entirely disposable duodenoscopes on the market that hospitals in the United States can, and should, transition to these devices and end use of reusable duodenoscopes with fixed endcaps. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Duodenoscope, Endoscope, ERCP, Hospital Infection, Infections More Lawsuit Stories Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit February 20, 2026 Judge Clears DraftKings Lawsuit Over Deceptive Practices To Move Forward February 20, 2026 Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients February 20, 2026 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: 3 days ago) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026) MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 4 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026) $7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 5 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)
Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit February 20, 2026
Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients February 20, 2026
Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: 3 days ago) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)
MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 4 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026)
$7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 5 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)